The GPCR ADGRF5 has been shown to be a regulator of breast cancer metastasis, with knock out of ADGRF5 in triple negative breast cancer cells, reducing metastasis in mouse models. This evidence concerns the gene ADGRF5 and triple-negative breast carcinoma.